CD19 and non-small cell lung carcinoma: We compared the expression of S15 on CD19+ B cells, CD3+ T cells and CD14+ monocyte cell populations within human PBMCs relative to H460 NSCLC and Panc-1 PDAC cancer cells, and found detectable but markedly lower S15 expression relative to the cancer cells (Figure S2).